NO20051928L - Tieno [3,2-b] pyridin-6-karbonitriler og tieno [2,3-b] pyridin-5-karbonitriler som proteasekinase inhibitorer. - Google Patents
Tieno [3,2-b] pyridin-6-karbonitriler og tieno [2,3-b] pyridin-5-karbonitriler som proteasekinase inhibitorer.Info
- Publication number
- NO20051928L NO20051928L NO20051928A NO20051928A NO20051928L NO 20051928 L NO20051928 L NO 20051928L NO 20051928 A NO20051928 A NO 20051928A NO 20051928 A NO20051928 A NO 20051928A NO 20051928 L NO20051928 L NO 20051928L
- Authority
- NO
- Norway
- Prior art keywords
- carbonitriles
- pyridine
- tieno
- thieno
- kinase inhibitors
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title 1
- 239000004365 Protease Substances 0.000 title 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title 1
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 206010052779 Transplant rejections Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000030761 polycystic kidney disease Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42886202P | 2002-11-25 | 2002-11-25 | |
PCT/US2003/036206 WO2004048386A2 (fr) | 2002-11-25 | 2003-11-14 | Thieno[3,2-b]pyridine-6-carbonitriles et thieno[2,3-b]pyridine-5-carbonitriles en tant qu'inhibiteurs de proteine kinase |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20051928D0 NO20051928D0 (no) | 2005-04-20 |
NO20051928L true NO20051928L (no) | 2005-08-19 |
Family
ID=32393469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20051928A NO20051928L (no) | 2002-11-25 | 2005-04-20 | Tieno [3,2-b] pyridin-6-karbonitriler og tieno [2,3-b] pyridin-5-karbonitriler som proteasekinase inhibitorer. |
Country Status (20)
Country | Link |
---|---|
US (1) | US6987116B2 (fr) |
EP (1) | EP1565474A2 (fr) |
JP (1) | JP2006509760A (fr) |
KR (1) | KR20050086770A (fr) |
CN (1) | CN1714092A (fr) |
AR (1) | AR042087A1 (fr) |
AU (1) | AU2003290802A1 (fr) |
BR (1) | BR0316534A (fr) |
CA (1) | CA2502614A1 (fr) |
CL (1) | CL2003002287A1 (fr) |
EC (1) | ECSP055802A (fr) |
MX (1) | MXPA05004744A (fr) |
NI (1) | NI200500089A (fr) |
NO (1) | NO20051928L (fr) |
NZ (1) | NZ540104A (fr) |
RU (1) | RU2005120018A (fr) |
TW (1) | TW200412950A (fr) |
UA (1) | UA81000C2 (fr) |
WO (1) | WO2004048386A2 (fr) |
ZA (1) | ZA200504238B (fr) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7276519B2 (en) * | 2002-11-25 | 2007-10-02 | Wyeth | Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
FR2862647B1 (fr) * | 2003-11-25 | 2008-07-04 | Aventis Pharma Sa | Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant |
JP5096142B2 (ja) | 2004-07-30 | 2012-12-12 | メチルジーン インコーポレイテッド | Vegfレセプターおよびhgfレセプターシグナル伝達の阻害剤 |
GB0423653D0 (en) * | 2004-10-25 | 2004-11-24 | Piramed Ltd | Pharmaceutical compounds |
ES2623221T3 (es) * | 2005-05-20 | 2017-07-10 | Methylgene Inc | Inhibidores de la señalización del receptor de VEGF y del receptor de HGF |
ES2473341T3 (es) | 2005-05-20 | 2014-07-04 | Methylgene Inc | Inhibidores de la se�alizaci�n del receptor del VEGF y del receptor del HGF |
WO2007035428A1 (fr) | 2005-09-15 | 2007-03-29 | Bristol-Myers Squibb Company | Inhibiteurs de la kinase met |
AR056200A1 (es) * | 2005-09-27 | 2007-09-26 | Wyeth Corp | Tieno [2,3-b]piridin-5-carbonitrilos como inhibidores de proteina quinasa |
US7547782B2 (en) | 2005-09-30 | 2009-06-16 | Bristol-Myers Squibb Company | Met kinase inhibitors |
AR059246A1 (es) * | 2006-01-30 | 2008-03-19 | Array Biopharma Inc | Compuestos heterobiciclicos de tiofeno y metodos de uso |
GB0601962D0 (en) * | 2006-01-31 | 2006-03-15 | Ucb Sa | Therapeutic agents |
WO2007089716A2 (fr) * | 2006-02-01 | 2007-08-09 | The Regents Of The University Of California | Utilisation de composés d'aminopyrimidine dans le traitement de troubles immunitaires |
WO2007092153A2 (fr) * | 2006-02-08 | 2007-08-16 | Wyeth | Preparation de 7-alcenyl-3-quinoleinecarbonitriles par l'intermediaire d'une reaction de couplage induite par palladium |
CA2655128A1 (fr) * | 2006-06-08 | 2007-12-21 | Array Biopharma Inc. | Quinolines et methodes d'utilisation |
ES2528797T3 (es) * | 2006-08-21 | 2015-02-12 | Genentech, Inc. | Compuestos de aza-benzotiofenilo y métodos de uso |
US20080085886A1 (en) * | 2006-08-21 | 2008-04-10 | Genentech, Inc. | Aza-benzofuranyl compounds and methods of use |
TW200821318A (en) * | 2006-09-26 | 2008-05-16 | Wyeth Corp | Process for the preparation of 4-hydroxythieno[2,3-b]pyridine-5-carbonitriles |
GB0714384D0 (en) * | 2007-07-23 | 2007-09-05 | Ucb Pharma Sa | theraputic agents |
AU2008293038B2 (en) | 2007-08-29 | 2013-08-29 | Mirati Therapeutics, Inc. | Inhibitors of protein tyrosine kinase activity |
US20090118276A1 (en) * | 2007-11-02 | 2009-05-07 | Wyeth | Thienopyrimidines, thienopyridines, and pyrrolopyrimidines as b-raf inhibitors |
EP2240494B1 (fr) * | 2008-01-21 | 2016-03-30 | UCB Biopharma SPRL | Dérivés de thiénopyridine utilisés comme inhibiteurs de mek |
AR070317A1 (es) * | 2008-02-06 | 2010-03-31 | Osi Pharm Inc | Furo (3,2-c) piridina y tieno (3,2-c) piridinas |
EP2332536A1 (fr) | 2008-03-05 | 2011-06-15 | MethylGene Inc. | Inhibiteurs d'activité de kinase de tyrosine de protéine |
GB0811304D0 (en) * | 2008-06-19 | 2008-07-30 | Ucb Pharma Sa | Therapeutic agents |
US8841462B2 (en) * | 2008-07-01 | 2014-09-23 | Robert A. Heald | Bicyclic heterocycles as MEK kinase inhibitors |
TW201204733A (en) | 2010-06-25 | 2012-02-01 | Kowa Co | Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
CN104797267A (zh) | 2012-06-26 | 2015-07-22 | 德玛医药 | 使用卫康醇、二乙酰二脱水卫矛醇、二溴卫矛醇或类似物或其衍生物治疗具有基因多型性或ahi1失调或突变患者的抗酪氨酸激酶抑制剂的恶性肿瘤的方法 |
ME03780B (fr) | 2013-01-15 | 2021-04-20 | Incyte Holdings Corp | Dérivés de thiazolecarboxamide et pyridinecarboxamide et leur utilisation comme inhibiteurs des kinases pim |
KR101468207B1 (ko) * | 2013-02-14 | 2014-12-01 | 한국화학연구원 | 신규한 싸이에노[3,2-b]피리딜 우레아 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 유로텐신-Ⅱ 수용체 활성 관련 질환의 예방 또는 치료용 약학적 조성물 |
WO2015027124A1 (fr) | 2013-08-23 | 2015-02-26 | Incyte Corporation | Composés de furo- et thiéno-pyridinecarboxamide utiles en tant qu'inhibiteurs de kinases pim |
AR105967A1 (es) | 2015-09-09 | 2017-11-29 | Incyte Corp | Sales de un inhibidor de pim quinasa |
TW201718546A (zh) | 2015-10-02 | 2017-06-01 | 英塞特公司 | 適用作pim激酶抑制劑之雜環化合物 |
US10596161B2 (en) | 2017-12-08 | 2020-03-24 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
EP3929185A4 (fr) * | 2019-02-19 | 2023-02-15 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Composé cyclique condensé contenant de l'azote, son procédé de préparation et son utilisation |
US11358971B2 (en) | 2019-07-03 | 2022-06-14 | H. Lundbeck A/S | Prodrugs of modulators of the NMDA receptor |
US11466027B2 (en) | 2019-07-03 | 2022-10-11 | H. Lundbeck A/S | Modulators of the NMDA receptor |
CN114269753B (zh) * | 2019-09-29 | 2024-03-05 | 四川科伦博泰生物医药股份有限公司 | 一种含氮并环类化合物,包含其的药物组合物,其制备方法及其用途 |
WO2022169866A1 (fr) * | 2021-02-05 | 2022-08-11 | Ptc Therapeutics Inc. | Procédés de traitement de l'ataxie spinocérébelleuse de type 3 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US45A (en) * | 1836-10-11 | Machine fob shelling cokm | ||
EP0126970A3 (fr) | 1983-04-27 | 1985-11-06 | Beecham Group Plc | Dérivés de thiénopyridine anxiolytiques et antidépresseurs |
AR004010A1 (es) * | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | Compuestos heterociclicos |
CN1280580A (zh) * | 1997-11-11 | 2001-01-17 | 辉瑞产品公司 | 用作抗癌药的噻吩并嘧啶和噻吩并吡啶衍生物 |
CN1144786C (zh) * | 1998-09-29 | 2004-04-07 | 美国氰胺公司 | 作为蛋白质酪氨酸激酶抑制剂的取代的3-氰基喹啉 |
JP3270834B2 (ja) * | 1999-01-27 | 2002-04-02 | ファイザー・プロダクツ・インク | 抗がん剤として有用なヘテロ芳香族二環式誘導体 |
GB9906566D0 (en) * | 1999-03-23 | 1999-05-19 | Zeneca Ltd | Chemical compounds |
DE60009888T2 (de) * | 1999-04-21 | 2005-04-21 | Wyeth Corp | Substituierte 3-cyano-[1.7], [1.5] und [1.8]naphthyridininhibitoren von tyrosin kinasen |
AU2464601A (en) * | 1999-12-29 | 2001-07-09 | Wyeth | Tricyclic protein kinase inhibitors |
AR035851A1 (es) * | 2000-03-28 | 2004-07-21 | Wyeth Corp | 3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidoras de proteina quinasas |
ATE277933T1 (de) * | 2000-06-06 | 2004-10-15 | Pfizer Prod Inc | Thiophenverbindungen zur verwendung als antikrebsmittel |
US20020004511A1 (en) * | 2000-06-28 | 2002-01-10 | Luzzio Michael Joseph | Thiophene derivatives useful as anticancer agents |
US7253184B2 (en) * | 2000-11-02 | 2007-08-07 | Astrazeneca Ab | 4-Substituted quinolines as antitumor agents |
CN1523991A (zh) | 2001-08-10 | 2004-08-25 | ��˹��ŵ�� | 单独的c-Src抑制剂或其与STI571的组合用于治疗白血病的用途 |
-
2003
- 2003-11-07 CL CL200302287A patent/CL2003002287A1/es unknown
- 2003-11-14 AU AU2003290802A patent/AU2003290802A1/en not_active Withdrawn
- 2003-11-14 EP EP03783385A patent/EP1565474A2/fr not_active Withdrawn
- 2003-11-14 NZ NZ540104A patent/NZ540104A/en unknown
- 2003-11-14 UA UAA200506270A patent/UA81000C2/uk unknown
- 2003-11-14 CA CA002502614A patent/CA2502614A1/fr not_active Abandoned
- 2003-11-14 KR KR1020057009358A patent/KR20050086770A/ko not_active Application Discontinuation
- 2003-11-14 MX MXPA05004744A patent/MXPA05004744A/es active IP Right Grant
- 2003-11-14 BR BR0316534-5A patent/BR0316534A/pt not_active IP Right Cessation
- 2003-11-14 CN CNA2003801039013A patent/CN1714092A/zh active Pending
- 2003-11-14 JP JP2004555437A patent/JP2006509760A/ja active Pending
- 2003-11-14 RU RU2005120018/04A patent/RU2005120018A/ru not_active Application Discontinuation
- 2003-11-14 WO PCT/US2003/036206 patent/WO2004048386A2/fr active Application Filing
- 2003-11-17 TW TW092132143A patent/TW200412950A/zh unknown
- 2003-11-19 AR ARP030104277A patent/AR042087A1/es not_active Application Discontinuation
- 2003-11-21 US US10/719,359 patent/US6987116B2/en not_active Expired - Fee Related
-
2005
- 2005-04-20 NO NO20051928A patent/NO20051928L/no not_active Application Discontinuation
- 2005-04-26 NI NI200500089A patent/NI200500089A/es unknown
- 2005-05-19 EC EC2005005802A patent/ECSP055802A/es unknown
- 2005-05-24 ZA ZA200504238A patent/ZA200504238B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200504238B (en) | 2009-09-30 |
CL2003002287A1 (es) | 2005-01-14 |
NI200500089A (es) | 2006-01-11 |
TW200412950A (en) | 2004-08-01 |
EP1565474A2 (fr) | 2005-08-24 |
AR042087A1 (es) | 2005-06-08 |
WO2004048386A3 (fr) | 2004-10-07 |
JP2006509760A (ja) | 2006-03-23 |
BR0316534A (pt) | 2005-10-04 |
RU2005120018A (ru) | 2006-05-10 |
US6987116B2 (en) | 2006-01-17 |
NO20051928D0 (no) | 2005-04-20 |
ECSP055802A (es) | 2005-08-11 |
KR20050086770A (ko) | 2005-08-30 |
NZ540104A (en) | 2007-05-31 |
CN1714092A (zh) | 2005-12-28 |
US20040138251A1 (en) | 2004-07-15 |
WO2004048386A9 (fr) | 2005-07-14 |
WO2004048386A2 (fr) | 2004-06-10 |
CA2502614A1 (fr) | 2004-06-10 |
UA81000C2 (en) | 2007-11-26 |
AU2003290802A1 (en) | 2004-06-18 |
MXPA05004744A (es) | 2005-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20051928L (no) | Tieno [3,2-b] pyridin-6-karbonitriler og tieno [2,3-b] pyridin-5-karbonitriler som proteasekinase inhibitorer. | |
NO20065489L (no) | Tieno[3,2-b]pyridin-6-karbonitriler som protein-kinase inhibitorer | |
SG145744A1 (en) | Process for the preparation of 4-amino-3- quinolinecarbonitriles | |
YU83302A (sh) | Jedinjenja pirolo (2,3-d) pirimidina kao imunosupresivni agensi | |
YU17003A (sh) | Spiroheterociklični nitrili upotrebljivi kao reverzibilni inhibitori cisteinskih proteaza | |
IL162461A0 (en) | Polymorphs of clopidogrel hydrogensulfate | |
WO2002102313A3 (fr) | Inhibiteurs pyrimidine de la phosphodiesterase (pde) 7 | |
SG156650A1 (en) | Thienopyrimidines useful as aurora kinase inhibitors | |
GB0217757D0 (en) | Novel compounds | |
WO2002087513A3 (fr) | Inhibiteurs heterocycliques fusionnes de phosphodiesterase (pde) 7 | |
HRP20020997B1 (en) | Serine protease inhibitors | |
GB0512099D0 (en) | Compounds | |
AU2003237305A1 (en) | Process of preparation of olanzapine form i | |
EP1383769A4 (fr) | Pyrazolo 3,4-d]pyrimidine-4-ones 6-substitutes utiles en tant qu'inhibiteurs de la kinase dependante des cyclines | |
AU2002235326A1 (en) | Processes for large scale production of tetrapyrroles | |
WO2004043379A3 (fr) | Composes chimiques | |
WO2002076396A3 (fr) | Composes utiles en tant qu'inhibiteurs de kinase pour le traitement de maladies hyperproliferatives | |
DK1501838T3 (da) | Fremgangsmåde til fremstilling af clopidogrel | |
PT1469853E (pt) | Utilização de 4-(2-fluorofenil)-6-metil-2-(1-piperazinil)-tieno[2,3-d]pirimidina para o tratamento da incontinência urinária | |
WO2005056563A3 (fr) | Procedes | |
EP1436279B8 (fr) | Composes chimiques | |
PL1963335T3 (pl) | Proces wytwarzania olanzapiny | |
MXJL02000016A (es) | Proceso industrial para la construccion masiva de edificaciones de concreto. | |
UA86772C2 (en) | Process for the preparation of the polymorph form of methyl (s)-(+)-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridine-5-yl-acetate hydrogensulfate | |
GB0112061D0 (en) | Process for the production of quinazolines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |